Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02566473 · ClinicalTrials.gov registry record

FORCE-TJR: Improving Orthopedic Outcomes Through a National TJR Registry

A clinical trial of Osteoarthritis, sponsored by University of Massachusetts, Worcester.

Active
Registry status
30,000
Enrollment target
1
Study location

NCT02566473: Active study of Osteoarthritis, sponsored by University of Massachusetts, Worcester.

NCT02566473 is a study of Osteoarthritis that is active but no longer recruiting, run by University of Massachusetts, Worcester. The registered enrollment target is 30,000 participants, above the 596-participant average among 135 other Osteoarthritis trials with a reported enrollment target (4934% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02566473, a study of Osteoarthritis, is active but no longer recruiting, sponsored by University of Massachusetts, Worcester.

ACTIVE NOT RECRUITING
Registry status
30,000 participants
Enrollment target
1
Study location

Study Summary

Aim 1. Establish a national registry of diverse patients of orthopedic surgeons representing all regions of the country and varied hospital and surgeon practice settings (e.g., urban/rural, low and high volume) to ensure that registry analyses and research reflect typical clinical practice thereby providing optimal guidance for patients, clinicians, and national healthcare policymakers. Collect pre-operative and post-operative patient reported outcomes (PROs) for pain and function. Aim 2: Develop new and transformative comparative effectiveness tools useful to both clinical practice and healthcare policy. Aim 3. Broadly disseminate surveillance reports for adverse events, such as implant revision, hip dislocation, knee manipulation, and identify important variation to inform quality improvement priorities.

Primary Outcome

Collection of patient reported pain composite score from the HOOS/KOOS measure

Conditions Studied

Study Locations (1)

Massachusetts

  • University of Massachusetts Memorial Health Center; Arthritis and Total Joint Center - Worcester

Trial Details

FieldValue
Enrollment Target 30,000 participants
Start Date 2011-04
Est. Completion 2031-04

What the registry record for NCT02566473 still lists

NCT02566473 is an observational study that tracks outcomes without assigning an intervention. Its 30,000 participants enrollment target places it among the larger protocols in the corpus, above the 596-participant average among 135 other Osteoarthritis trials with a reported enrollment target (4934% higher).

The record links to 1 condition, with Osteoarthritis appearing as the primary indexed condition, and to 0 interventions.

NCT02566473 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02566473 about?

NCT02566473 is a clinical study titled "FORCE-TJR: Improving Orthopedic Outcomes Through a National TJR Registry". Aim 1. Establish a national registry of diverse patients of orthopedic surgeons representing all regions of the country and varied hospital and surgeon practice settings (e.g., urban/rural, low and high volume) to ensure that registry analyses and research reflect typical clinical practice thereby p...

What is the current status of trial NCT02566473?

This trial is currently active not recruiting. The enrollment target is 30,000 participants. The study started on 2011-04. Estimated completion is 2031-04.

What conditions does trial NCT02566473 study?

This clinical trial studies the following conditions: Osteoarthritis.

Who is sponsoring clinical trial NCT02566473?

This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02566473 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02566473's enrollment target sits among peer trials

30,000 1st of 135 higher than 135 of 135 other Osteoarthritis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00684580 · 30,000 participants

    Protocol For Collecting Data On Patients With Childhood Cancer

  • NCT03053193 · 30,000 participants

    MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

  • NCT03689595 · 30,000 participants

    Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)

  • NCT04834869 · 30,000 participants

    COVID-19 Vaccines Safety Tracking (CoVaST)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02566473, the US trial registry maintained by the National Library of Medicine. NCT02566473 (large enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.